• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗抑郁药反应的时间进程:早期改善的预测价值及附加心理治疗的效果

Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.

作者信息

van Calker Dietrich, Zobel Ingo, Dykierek Petra, Deimel Christoph Michael, Kech Sabine, Lieb Klaus, Berger Mathias, Schramm Elisabeth

机构信息

Department of Psychiatry and Psychotherapy, University Medical Centre Freiburg, Germany.

出版信息

J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.

DOI:10.1016/j.jad.2008.07.023
PMID:18849079
Abstract

BACKGROUND

The full response to antidepressant pharmacotherapy is evident only after several weeks, but considerable improvements may already be visible within the first two weeks. Little is known about the potential influence of additional psychotherapy on the speed of response to antidepressant treatment. We have analysed in more severely depressed inpatients treated with antidepressants i) the predictive value of early improvement for later response and ii) the impact of additional psychotherapy on the time course of response.

METHODS

124 patients with a major depression referred for hospitalized care were randomized to 5 weeks of sertraline (or amitriptyline as a second choice) plus either additional Interpersonal Psychotherapy modified for inpatients (IPT) or Clinical Management (CM). "Improvement" was defined as a decrease of > or = 20% on the 17-item Hamilton Rating Scale for Depression (HAMD). "Onset of response" was defined as sustained improvement (without any subsequent increase in the HAMD) culminating in 50% decrease on the HAMD by week 5.

RESULTS

Early improvement within two weeks was highly predictive of later stable response (> or = 50% decrease on the HAMD at weeks 4 and 5) or stable remission (HAMD score of < or = 7 at weeks 4 and 5), irrespective of the type of medication or additional IPT or CM. Survival analysis of the ITT sample revealed that patients of the IPT group had a shorter time to "onset of response" than patients in the CM group (median: 12 vs. 30 days; p=0.041, Log Rank). However, there was no significant difference in the time to onset of response, when more stringent conditions were used.

LIMITATIONS

Due to ethical restrictions a comparison with an untreated placebo group could not be performed.

CONCLUSIONS

Early improvement is highly predictive for later stable response or remission in more severely depressed inpatients. In combination therapy, the additional benefit of psychotherapy occurs at least as rapid as the response to antidepressants.

摘要

背景

抗抑郁药物治疗的完全疗效要在数周后才明显显现,但在最初两周内可能就已出现显著改善。关于额外的心理治疗对抗抑郁治疗反应速度的潜在影响,人们了解甚少。我们对使用抗抑郁药物治疗的重度抑郁症住院患者进行了分析,一是早期改善对后期反应的预测价值,二是额外的心理治疗对反应时间进程的影响。

方法

124名因重度抑郁症需住院治疗的患者被随机分为两组,一组接受5周的舍曲林治疗(若舍曲林不可用则选用阿米替林),并额外接受针对住院患者的人际心理治疗(IPT)或临床管理(CM)。“改善”定义为在17项汉密尔顿抑郁量表(HAMD)上得分下降≥20%。“反应开始”定义为持续改善(HAMD得分无后续升高),到第5周时HAMD得分下降50%。

结果

无论使用何种药物,以及是否额外接受IPT或CM,两周内的早期改善都高度预测后期的稳定反应(第4周和第5周时HAMD得分下降≥50%)或稳定缓解(第4周和第5周时HAMD得分≤7)。意向性分析样本的生存分析显示,IPT组患者达到“反应开始”的时间比CM组患者短(中位数:12天对30天;p = 0.041,对数秩检验)。然而,当采用更严格的条件时,反应开始时间没有显著差异。

局限性

由于伦理限制,无法与未治疗的安慰剂组进行比较。

结论

早期改善对重度抑郁症住院患者后期的稳定反应或缓解具有高度预测性。在联合治疗中,心理治疗的额外益处至少与抗抑郁药物的反应速度一样快。

相似文献

1
Time course of response to antidepressants: predictive value of early improvement and effect of additional psychotherapy.抗抑郁药反应的时间进程:早期改善的预测价值及附加心理治疗的效果
J Affect Disord. 2009 Apr;114(1-3):243-53. doi: 10.1016/j.jad.2008.07.023. Epub 2008 Oct 11.
2
Does early improvement triggered by antidepressants predict response/remission? Analysis of data from a naturalistic study on a large sample of inpatients with major depression.抗抑郁药引发的早期改善能否预测疗效/缓解情况?对大量重度抑郁症住院患者的自然主义研究数据进行分析。
J Affect Disord. 2009 Jun;115(3):439-49. doi: 10.1016/j.jad.2008.10.011. Epub 2008 Nov 22.
3
Efficacy of Interpersonal Psychotherapy plus pharmacotherapy in chronically depressed inpatients.人际心理治疗联合药物治疗对慢性抑郁症住院患者的疗效。
J Affect Disord. 2008 Jul;109(1-2):65-73. doi: 10.1016/j.jad.2007.10.013. Epub 2007 Dec 11.
4
Metyrapone as additive treatment in major depression: a double-blind and placebo-controlled trial.甲吡酮作为重度抑郁症的辅助治疗:一项双盲安慰剂对照试验。
Arch Gen Psychiatry. 2004 Dec;61(12):1235-44. doi: 10.1001/archpsyc.61.12.1235.
5
Combination treatment for acute depression is superior only when psychotherapy is added to medication.急性抑郁症的联合治疗仅在药物治疗基础上加用心理治疗时才更具优势。
Psychother Psychosom. 2007;76(5):289-97. doi: 10.1159/000104705.
6
Continuation and long-term maintenance treatment with Hypericum extract WS 5570 after recovery from an acute episode of moderate depression--a double-blind, randomized, placebo controlled long-term trial.中度抑郁症急性发作康复后使用金丝桃提取物 WS 5570 进行延续性和长期维持治疗——一项双盲、随机、安慰剂对照的长期试验。
Eur Neuropsychopharmacol. 2008 Nov;18(11):803-13. doi: 10.1016/j.euroneuro.2008.06.006. Epub 2008 Aug 9.
7
Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies.度洛西汀每日一次60毫克的起效时间:双盲、安慰剂对照研究。
J Psychiatr Res. 2005 Mar;39(2):161-72. doi: 10.1016/j.jpsychires.2004.05.005.
8
Identifying patients at risk of complete nonresponse in the outpatient treatment of depression.识别抑郁症门诊治疗中完全无反应风险的患者。
Psychother Psychosom. 2008;77(6):358-64. doi: 10.1159/000151389. Epub 2008 Aug 14.
9
Treatment strategies in patients with major depression not responding to first-line sertraline treatment. A randomised study of extended duration of treatment, dose increase or mianserin augmentation.对一线舍曲林治疗无反应的重度抑郁症患者的治疗策略。延长治疗时间、增加剂量或米安色林增效的随机研究。
Psychopharmacology (Berl). 2002 May;161(2):143-51. doi: 10.1007/s00213-002-0999-0. Epub 2002 Mar 20.
10
Partial sleep deprivation therapy combined with sertraline induces more rapid improvements in quality of life items in major depressive disorder.部分睡眠剥夺疗法联合舍曲林能更快速地改善重度抑郁症患者的生活质量项目。
J Affect Disord. 2005 Sep;88(1):75-8. doi: 10.1016/j.jad.2005.04.008.

引用本文的文献

1
The Role of Daily Steps in the Treatment of Major Depressive Disorder: Secondary Analysis of a Randomized Controlled Trial of a 6-Month Internet-Based, Mindfulness-Based Cognitive Behavioral Therapy Intervention for Youth.每日步数在重度抑郁症治疗中的作用:一项针对青少年的为期6个月的基于互联网的正念认知行为疗法干预随机对照试验的二次分析
Interact J Med Res. 2023 Dec 8;12:e46419. doi: 10.2196/46419.
2
A National Retrospective Study of Antidepressants' Effects on Overdose and Self-Harm Among Adults Treated With Opioid Analgesics.一项全国性的回顾性研究:抗抑郁药对接受阿片类镇痛药治疗的成年人的过量用药和自残行为的影响。
Psychiatr Serv. 2023 Jan 1;74(1):24-30. doi: 10.1176/appi.ps.20220070. Epub 2022 Jun 30.
3
Cortical Thickness Predicts Response Following 2 Weeks of SSRI Regimen in First-Episode, Drug-Naive Major Depressive Disorder: An MRI Study.
皮质厚度可预测首发、未服用过药物的重度抑郁症患者在接受2周选择性5-羟色胺再摄取抑制剂(SSRI)治疗方案后的反应:一项磁共振成像(MRI)研究
Front Psychiatry. 2022 Feb 22;12:751756. doi: 10.3389/fpsyt.2021.751756. eCollection 2021.
4
Resting-State fMRI in Predicting Response to Treatment With SSRIs in First-Episode, Drug-Naive Patients With Major Depressive Disorder.静息态功能磁共振成像预测首发、未用过药物的重度抑郁症患者对选择性5-羟色胺再摄取抑制剂治疗的反应
Front Neurosci. 2022 Feb 16;16:831278. doi: 10.3389/fnins.2022.831278. eCollection 2022.
5
Influence of eight ABCB1 polymorphisms on antidepressant response in a prospective cohort of treatment-free Russian patients with moderate or severe depression: An explorative psychopharmacological study with naturalistic design.八个体 ABCB1 多态性对无治疗俄罗斯中重度抑郁患者抗抑郁反应的影响:一项探索性精神药理学研究,采用自然设计。
Hum Psychopharmacol. 2022 May;37(3):e2826. doi: 10.1002/hup.2826. Epub 2021 Nov 17.
6
The Potential Use of Peripheral Blood Mononuclear Cells as Biomarkers for Treatment Response and Outcome Prediction in Psychiatry: A Systematic Review.外周血单核细胞作为精神科治疗反应和预后预测生物标志物的潜在应用:系统评价。
Mol Diagn Ther. 2021 May;25(3):283-299. doi: 10.1007/s40291-021-00516-8. Epub 2021 May 12.
7
Treatment response classes in major depressive disorder identified by model-based clustering and validated by clinical prediction models.基于模型聚类识别的重度抑郁症治疗反应类别,并通过临床预测模型验证。
Transl Psychiatry. 2019 Aug 5;9(1):187. doi: 10.1038/s41398-019-0524-4.
8
Variance of the global signal as a pretreatment predictor of antidepressant treatment response in drug-naïve major depressive disorder.全球信号的变异性作为预处理预测因子,预测药物初治的重度抑郁症患者对抗抑郁治疗的反应。
Brain Imaging Behav. 2018 Dec;12(6):1768-1774. doi: 10.1007/s11682-018-9845-9.
9
Early Symptom Improvement as a Predictor of Response to Extended Release Quetiapine in Major Depressive Disorder.早期症状改善作为重度抑郁症患者对缓释喹硫平反应的预测指标
J Clin Psychopharmacol. 2015 Dec;35(6):706-10. doi: 10.1097/JCP.0000000000000416.
10
Time Course of Behavioral Alteration and mRNA Levels of Neurotrophic Factor Following Stress Exposure in Mouse.应激暴露后小鼠行为改变及神经营养因子mRNA水平的时间进程
Cell Mol Neurobiol. 2015 Aug;35(6):807-17. doi: 10.1007/s10571-015-0174-x. Epub 2015 Mar 28.